153 related articles for article (PubMed ID: 25425293)
21. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1.
Guéguen P; Dalekos G; Nousbaum JB; Zachou K; Putterman C; Youinou P; Renaudineau Y
J Clin Immunol; 2006 Nov; 26(6):495-505. PubMed ID: 17001515
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein.
Vitozzi S; Lapierre P; Djilali-Saiah I; Alvarez F
J Immunol Methods; 2002 Apr; 262(1-2):103-10. PubMed ID: 11983223
[TBL] [Abstract][Full Text] [Related]
23. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.
Amin K; Rasool AH; Hattem A; Al-Karboly TA; Taher TE; Bystrom J
World J Gastroenterol; 2017 Feb; 23(8):1345-1352. PubMed ID: 28293081
[TBL] [Abstract][Full Text] [Related]
24. [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C].
Pavić S; Simonović J; Boricić I; Svirtlih N
Srp Arh Celok Lek; 2003; 131(11-12):437-42. PubMed ID: 15114784
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Clin Rev Allergy Immunol; 2022 Oct; 63(2):124-137. PubMed ID: 34491531
[TBL] [Abstract][Full Text] [Related]
26. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.
Kimura M; Tatsumi KI; Tada H; Izumi Y; Kaneko A; Kato M; Masuzawa M; Ikemoto M; Yabusaki Y; Hidaka Y; Amino N
Clin Chim Acta; 2002 Feb; 316(1-2):155-64. PubMed ID: 11750286
[TBL] [Abstract][Full Text] [Related]
27. Significance of smooth muscle/anti-actin autoantibodies in celiac disease.
Pedreira S; Sugai E; Moreno ML; Vázquez H; Niveloni S; Smecuol E; Mazure R; Kogan Z; Mauriño E; Bai JC
Acta Gastroenterol Latinoam; 2005; 35(2):83-93. PubMed ID: 16127984
[TBL] [Abstract][Full Text] [Related]
28. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune liver disease serology in acute hepatitis E virus infection.
Terziroli Beretta-Piccoli B; Ripellino P; Gobbi C; Cerny A; Baserga A; Di Bartolomeo C; Bihl F; Deleonardi G; Melidona L; Grondona AG; Mieli-Vergani G; Vergani D; Muratori L;
J Autoimmun; 2018 Nov; 94():1-6. PubMed ID: 30336842
[TBL] [Abstract][Full Text] [Related]
30. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
31. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
32. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up.
Csepregi A; Szodoray P; Zeher M
Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
35. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.
Zamanou A; Tsirogianni A; Terzoglou C; Balafas A; Economidou I; Lymberi P
J Clin Lab Anal; 2002; 16(4):194-201. PubMed ID: 12112392
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
[TBL] [Abstract][Full Text] [Related]
37. Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1.
Zachou K; Oikonomou K; Renaudineau Y; Chauveau A; Gatselis N; Youinou P; Dalekos GN
Aliment Pharmacol Ther; 2012 Jan; 35(1):116-25. PubMed ID: 22050113
[TBL] [Abstract][Full Text] [Related]
38. ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis.
Bretherton L; Brown C; Pedersen JS; Toh BH; Clarke FM; Mackay IR; Gust ID
Clin Exp Immunol; 1983 Mar; 51(3):611-6. PubMed ID: 6342886
[TBL] [Abstract][Full Text] [Related]
39. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
40. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
